Cancer drug response prediction with surrogate modeling-based graph neural architecture search
Bioinformatics · 2023
DOI: 10.1093/bioinformatics/btad478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, 2023. Verfasst von Babatounde Moctard Oloulade und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer Science and Engineering, Central South University, Changsha 410083, China. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Motivation Understanding drug–response differences in cancer treatments is one of the most challenging aspects of personalized medicine. Recently, graph neural networks (GNNs) have become state-of-the-art methods in many graph representation learning scenarios in bioinformatics. However, building an optimal handcrafted GNN model for a particular drug sensitivity dataset requires manual design and fine-tuning of the hyperparameters for the GNN model, which is time-consuming and requires expert knowledge. Results In this work, we propose AutoCDRP, a novel framework for automated cancer drug–response predictor using GNNs. Our approach leverages surrogate modeling to efficiently search for the most effective GNN architecture. AutoCDRP uses a surrogate model to predict the performance of GNN architectures sampled from a search space, allowing it to select the optimal architecture based on evaluation performance. Hence, AutoCDRP can efficiently identify the optimal GNN architecture by exploring the performance of all GNN architectures in the search space. Through comprehensive experiments on two benchmark datasets, we demonstrate that the GNN architecture generated by AutoCDRP surpasses state-of-the-art designs. Notably, the optimal GNN architecture identified by AutoCDRP consistently outperforms the best baseline architecture from the first epoch, providing further evidence of its effectiveness. Availability and implementation https://github.com/BeObm/AutoCDRP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Computer Science and Engineering, Central South University, Changsha 410083, China.
ORCID-Profile: Babatounde Moctard Oloulade
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Oloulade, B. M., Gao, J., Chen, J., Al-Sabri, R., & Wu, Z. (2023). Cancer drug response prediction with surrogate modeling-based graph neural architecture search. Bioinformatics. https://doi.org/10.1093/bioinformatics/btad478
Vancouver
Oloulade BM, Gao J, Chen J, Al-Sabri R, Wu Z. Cancer drug response prediction with surrogate modeling-based graph neural architecture search. Bioinformatics. 2023. doi:10.1093/bioinformatics/btad478
BibTeX
@article{Oloulade2023,
author = {Oloulade, Babatounde Moctard and Gao, Jianliang and Chen, Jiamin and Al-Sabri, Raeed and Wu, Zhenpeng},
title = {Cancer drug response prediction with surrogate modeling-based graph neural architecture search},
journal = {Bioinformatics},
year = {2023},
doi = {10.1093/bioinformatics/btad478}
}
EUVIMED